Results 31 to 40 of about 1,185,287 (314)

Autologous Graft-versus-Tumor Effect: Reality or Fiction?

Advances in Hematology, 2016
In contrast to allogeneic hematopoietic stem cell transplantation, the current dogma is not an evidence of graft-versus-tumor effect in autologous hematopoietic stem cell transplantation; thus, it is assumed that autologous hematopoietic stem cell ...
Luis F. Porrata
doaj   +1 more source

Rituximab after Autologous Stem‐Cell Transplantation in Mantle‐Cell Lymphoma

New England Journal of Medicine, 2017
BACKGROUND Mantle‐cell lymphoma is generally incurable. Despite high rates of complete response after initial immunochemotherapy followed by autologous stem‐cell transplantation, patients have relapses.
S. le Gouill, C. Thieblemont, L. Obéric, A. Moreau, K. Bouabdallah, C. Dartigeas, G. Damaj, T. Gastinne, V. Ribrag, P. Feugier, O. Casasnovas, H. Zerazhi, C. Haioun, H. Maisonneuve, R. Houot, F. Jardin, E. Van Den Neste, O. Tournilhac, K. Le Dû, F. Morschhauser, G. Cartron, L. Fornecker, D. Canioni, M. Callanan, M. Béné, G. Salles, H. Tilly, T. Lamy, R. Gressin, O. Hermine   +29 more
semanticscholar   +1 more source

Younger donor’s age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Haematologica, 2012
Background How tandem autologous-allogeneic stem cell transplantation should be integrated in the treatment of multiple myeloma remains controversial.
Claire Fabre, Serge Koscielny, Mohamad Mohty, Nathalie Fegueux, Didier Blaise, Natacha Maillard, Reza Tabrizi, Mauricette Michallet, Gérard Socié, Ibrahim Yakoub-Agha, Frédéric Garban, Madalina Uzunov, Sylvie François, Nathalie Contentin, Simona Lapusan, Jean-Henri Bourhis   +15 more
doaj   +1 more source

Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma

Cancer Medicine, Volume 11, Issue 24, Page 4889-4899, December 2022., 2022
This analysis assessed safety and efficacy of lisocabtagene maraleucel (liso‐cel), an autologous CD‐19‐directed CAR T‐cell product, in Japanese patients with R/R aggressive LBCL in Cohort 3 of TRANSCEND WORLD (NCT03484702). Liso‐cel demonstrated meaningful efficacy and a manageable safety profile in Japanese patients with R/R LBCL.
Shinichi Makita, Go Yamamoto, Dai Maruyama, Yuki Asano‐Mori, Daisuke Kaji, Revathi Ananthakrishnan, Ken Ogasawara, Lara Stepan, Claudia Schusterbauer, Nils Rettby, Jens Hasskarl, Koji Izutsu   +11 more
wiley   +1 more source

Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease

Haematologica, 2009
High-dose melphalan chemotherapy and autologous peripheral blood stem cell transplantation has been shown to result in durable hematologic response and prolonged overall survival in systemic AL amyloidosis.
Saulius Girnius, David C. Seldin, Martha Skinner, Kathleen T. Finn, Karen Quillen, Gheorghe Doros, Vaishali Sanchorawala   +6 more
doaj   +1 more source

Collective effects in flow-driven cell migration [PDF]

arXiv, 2023
Autologous chemotaxis is the process in which cells secrete and detect molecules to determine the direction of fluid flow. Experiments and theory suggest that autologous chemotaxis fails at high cell densities because molecules from other cells interfere with a given cell's signal.
arxiv  

A predictive model for kidney transplant graft survival using machine learning [PDF]

4th International Conference on Computer Science and Information Technology (COMIT 2020), November 28-29, 2020, Dubai, UAE. ISBN: 978-1-925953-30-5. Volume 10, Number 16, 2020
Kidney transplantation is the best treatment for end-stage renal failure patients. The predominant method used for kidney quality assessment is the Cox regression-based, kidney donor risk index. A machine learning method may provide improved prediction of transplant outcomes and help decision-making. A popular tree-based machine learning method, random
arxiv   +1 more source

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

, 1996
Background The median survival of patients with myeloma after conventional chemotherapy is three years or less. Promising results have been reported with high-dose therapy supported by autologous bone marrow transplantation.
M. Attal, J. Harousseau, A. Stoppa, J. Sotto, J. Fuzibet, J. Rossi, P. Casassus, H. Maisonneuve, T. Facon, N. Ifrah, C. Payen, R. Bataille   +11 more
semanticscholar   +1 more source

B–NHL Cases in a Tertiary Pediatric Hematology—Oncology Department: A 20-Year Retrospective Cohort Study

Life
Non-Hodgkin lymphoma (NHL) is among the five most common pediatric cancer diagnoses in children and adolescents and consists of a heterogeneous group of lymphoid tissue malignancies –with B-cell-derived NHL accounting for nearly 80% of cases.
Ioannis Kyriakidis, Iordanis Pelagiadis, Maria Stratigaki, Nikolaos Katzilakis, Eftichia Stiakaki   +4 more
doaj   +1 more source

Clinical Allogeneic and Autologous Islet Cell Transplantation: Update [PDF]

Diabetes & Metabolism Journal, 2011
Islet cell transplantation is categorized as a β-cell replacement therapy for diabetic patients who lack the ability to secrete insulin. Allogeneic islet cell transplantation is for the treatment of type 1 diabetes, and autologous islet cell ...
Shinichi Matsumoto
doaj   +1 more source